Saturday, December 12th, 2020
Special Edition: Vaccine Data, Unknowns & Logistics
Listen below for the interview:
Tune in weekdays for 10-min news roundups:
Today we’re talking about the Pfizer COVID-19 vaccine, which the FDA authorized for emergency use on Friday evening.
So, our guest expert, Dr. William Moss, who is Executive Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health, will be sharing his take on the data, what’s still unknown about the vaccines, and the challenges we may face when they start going out to the public.
Today’s episode is brought to you by Blinkist.
Guest: William Moss, MD
William Moss is a Professor in the Departments of Epidemiology, International Health and Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, Executive Director of the International Vaccine Access Center, and a Deputy Director at the Johns Hopkins Malaria Research Institute. He is a pediatrician with subspecialty training in infectious diseases, and has worked in Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India among other countries. His broad research interests are the epidemiology and control of childhood infections in resource-poor countries. The specific focus of his current research is in understanding the impact of the HIV epidemic on measles control and eradication, the epidemiology and control of malaria in southern Africa, the use of serosurveillance to guide immunization programs, and the care and treatment of HIV-infected children in rural Zambia.